IN2014DN03277A - - Google Patents

Download PDF

Info

Publication number
IN2014DN03277A
IN2014DN03277A IN3277DEN2014A IN2014DN03277A IN 2014DN03277 A IN2014DN03277 A IN 2014DN03277A IN 3277DEN2014 A IN3277DEN2014 A IN 3277DEN2014A IN 2014DN03277 A IN2014DN03277 A IN 2014DN03277A
Authority
IN
India
Prior art keywords
crystal
hydrochloride
compound
crystals
formula
Prior art date
Application number
Other languages
English (en)
Inventor
Ichiro Araya
Akinori Goto
Wataru Minagawa
Keiko Funada
Muneki Nagao
Original Assignee
Kyorin Seiyaku Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Seiyaku Kk filed Critical Kyorin Seiyaku Kk
Publication of IN2014DN03277A publication Critical patent/IN2014DN03277A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
IN3277DEN2014 2011-11-10 2012-11-09 IN2014DN03277A (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2011246209 2011-11-10
JP2012071739 2012-03-27
PCT/JP2012/007195 WO2013069297A1 (fr) 2011-11-10 2012-11-09 Cristal de l'acide 7-{(3s,4s)-3-[(cyclopropylamino)méthyl]-4- fluoropyrrolidin-1-yl}-6-fluoro-1-(2-fluoroéthyl)-8-méthoxy-4-oxo-1,4- dihydroquinoléine-3-carboxylique

Publications (1)

Publication Number Publication Date
IN2014DN03277A true IN2014DN03277A (fr) 2015-05-22

Family

ID=48289529

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3277DEN2014 IN2014DN03277A (fr) 2011-11-10 2012-11-09

Country Status (16)

Country Link
US (3) US9090587B2 (fr)
EP (2) EP2778159B1 (fr)
JP (4) JP5871948B2 (fr)
KR (2) KR102162208B1 (fr)
CN (2) CN103930414B (fr)
AU (1) AU2016273899B2 (fr)
BR (1) BR112014010765B1 (fr)
CA (1) CA2855022C (fr)
ES (2) ES2747303T3 (fr)
IN (1) IN2014DN03277A (fr)
NZ (1) NZ623808A (fr)
RU (2) RU2615509C2 (fr)
SA (1) SA112330992B1 (fr)
SG (2) SG10201608167UA (fr)
TW (1) TWI547492B (fr)
WO (1) WO2013069297A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SA112330992B1 (ar) * 2011-11-10 2015-09-13 كيورين فارماسوتيكال كو.، ليمتد صورة متبلرة من 7-{(s4، s3)-3-[(سيكلو بروبيل أمينو) ميثيل]-4-فلورو بيروليدين-1-يل}-6-فلورو-1-(2-فلورو إيثيل)- 8-ميثوكسي-4-أوكسو-1، 4-داي هيدرو كينولين-3- حمض كربوكسيلي
CN105338982B (zh) 2013-04-25 2017-10-10 杏林制药株式会社 固体药用组合物
CA2910121A1 (fr) * 2013-04-25 2014-10-30 Kyorin Pharmaceutical Co., Ltd. Composition pharmaceutique contenant un acide carboxylique 1,4-dihydroquinoleine, un excipient cellulosique et un agent de relargage
WO2014174848A1 (fr) * 2013-04-25 2014-10-30 杏林製薬株式会社 Comprimé
GB201402071D0 (en) 2014-02-07 2014-03-26 Galapagos Nv Novel salts and pharmaceutical compositions thereof for the treatment of inflammatory disorders
WO2016063544A1 (fr) * 2014-10-23 2016-04-28 杏林製薬株式会社 Composition pharmaceutique solide
EP3210607A4 (fr) * 2014-10-23 2018-06-06 Kyorin Pharmaceutical Co., Ltd. Composition pharmaceutique solide
CA2978261A1 (fr) * 2015-03-13 2016-09-22 Kyorin Pharmaceutical Co., Ltd. Agent de traitement d'une infection respiratoire
EP3305294A4 (fr) * 2015-06-02 2019-02-20 Kyorin Pharmaceutical Co., Ltd. Médicament aqueux
WO2016195020A1 (fr) * 2015-06-02 2016-12-08 杏林製薬株式会社 Médicament aqueux
CA2988092A1 (fr) * 2015-06-02 2016-12-08 Kyorin Pharmaceutical Co., Ltd. Formulation liquide aqueuse
TWI818910B (zh) 2017-06-16 2023-10-21 日商杏林製藥股份有限公司 吸入性肺炎、肺化膿症或肺膿瘍之治療劑
EA202090066A1 (ru) 2018-03-30 2020-04-15 Керин Фармасьютикал Ко., Лтд. Терапевтическое средство для лечения аспирационной пневмонии, легочного нагноения или абсцесса легких

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA944369B (en) * 1993-08-27 1995-02-13 Hokuriku Seuyaku Co Ltd 5-amino-8-methyl-7-pyrrolidinylquinoline-3-carboxylic acid derivative
CN1158846A (zh) * 1995-05-09 1997-09-10 昆山市康壮达兽药厂 盐酸氟哌酸的合成工艺
US20030119060A1 (en) 2001-08-10 2003-06-26 Desrosiers Peter J. Apparatuses and methods for creating and testing pre-formulations and systems for same
WO2003076428A1 (fr) * 2002-03-08 2003-09-18 Daiichi Pharmaceutical Co., Ltd. Derive d'acide quinolone-carboxylique
AU2004272414B2 (en) * 2003-09-10 2009-05-28 Kyorin Pharmaceutical Co., Ltd. 7-(4-substituted 3- cyclopropylaminomethyl-1- pyrrolidinyl) quinolonecarboxylic acid derivative
CN101003540A (zh) * 2006-01-18 2007-07-25 广州白云山制药股份有限公司广州白云山制药总厂 一种抗感染化合物和用途
SA112330992B1 (ar) * 2011-11-10 2015-09-13 كيورين فارماسوتيكال كو.، ليمتد صورة متبلرة من 7-{(s4، s3)-3-[(سيكلو بروبيل أمينو) ميثيل]-4-فلورو بيروليدين-1-يل}-6-فلورو-1-(2-فلورو إيثيل)- 8-ميثوكسي-4-أوكسو-1، 4-داي هيدرو كينولين-3- حمض كربوكسيلي

Also Published As

Publication number Publication date
US20140288310A1 (en) 2014-09-25
EP2778159B1 (fr) 2017-03-01
TWI547492B (zh) 2016-09-01
RU2014123567A (ru) 2015-12-20
JP6514069B2 (ja) 2019-05-15
CN103930414A (zh) 2014-07-16
RU2017109814A3 (fr) 2020-04-08
AU2016273899B2 (en) 2017-07-27
JPWO2013069297A1 (ja) 2015-04-02
BR112014010765A2 (pt) 2017-06-13
SA112330992B1 (ar) 2015-09-13
SG10201608167UA (en) 2016-11-29
TW201332991A (zh) 2013-08-16
CN103930414B (zh) 2016-01-20
CA2855022A1 (fr) 2013-05-16
AU2012337206A1 (en) 2014-05-22
EP2778159A4 (fr) 2015-06-03
AU2016273899A1 (en) 2017-01-12
EP2778159A1 (fr) 2014-09-17
SG11201401817TA (en) 2014-08-28
EP3112359A1 (fr) 2017-01-04
WO2013069297A1 (fr) 2013-05-16
KR20190065456A (ko) 2019-06-11
US9328089B2 (en) 2016-05-03
USRE47785E1 (en) 2019-12-31
US20150284361A1 (en) 2015-10-08
JP6349435B2 (ja) 2018-06-27
CN104945375A (zh) 2015-09-30
KR102162208B1 (ko) 2020-10-06
AU2012337206B2 (en) 2016-09-15
NZ623808A (en) 2015-07-31
JP6818719B2 (ja) 2021-01-20
JP2018158949A (ja) 2018-10-11
BR112014010765B1 (pt) 2020-07-14
JP5871948B2 (ja) 2016-03-01
ES2621664T3 (es) 2017-07-04
RU2615509C2 (ru) 2017-04-05
CN104945375B (zh) 2017-07-04
US9090587B2 (en) 2015-07-28
JP2017160243A (ja) 2017-09-14
ES2747303T3 (es) 2020-03-10
RU2017109814A (ru) 2019-01-23
JP2016027045A (ja) 2016-02-18
EP3112359B1 (fr) 2019-08-21
CA2855022C (fr) 2019-05-07
KR20140098074A (ko) 2014-08-07
AU2012337206A8 (en) 2016-09-22

Similar Documents

Publication Publication Date Title
IN2014DN03277A (fr)
NZ734896A (en) Novel 4-methoxy pyrrole derivatives or salts thereof and pharmaceutical composition comprising the same
PH12016500169A1 (en) Polymorph of syk inhibitors
EA201490759A1 (ru) Ингибиторы протеинкиназы
CR20140042A (es) Indazoles
SA515361086B1 (ar) Fasn مركبات وتركيبات جديدة لتثبيط
CR20130333A (es) Compuestos indol o análogos de los mismos útiles en el tratamiento de la degeneración macular relacionada con la edad (dmae)
PH12014501719A1 (en) Pyridone derivatives
IN2014MN02106A (fr)
JO3317B1 (ar) مركبات تترا هيدروبيرولو ثيازين
WO2014028597A3 (fr) Composés indazole et indole à substitution cyclohexyl et 3-cyclohexenyl
IN2014MN01897A (fr)
AU2012313888A8 (en) 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH
AU2012214029A8 (en) Rorgammat inhibitors
IN2014MN02459A (fr)
WO2012131710A3 (fr) Nouveau procédé pour la synthèse de dérivés d'indoline
MX368178B (es) Compuestos de ácido dimetilbenzoico.
EA201500930A1 (ru) Новые ингибиторы
MX359069B (es) Sal y formas cristalinas de inhibidor de quinasa tipo polo-4.
MA39866A (fr) Amides 2-amino-6-méthyl-4,4a,5,6-tétrahydropyrano[3,4-d][1,3]thiazin-8a(8h)-yl-1,3-thiazol-4-yle
CY1118079T1 (el) Μεθοδος παρασκευης του αλατος l-αργινινικης περινδοπριλης
MX2010006787A (es) Análogos halogenados de agentes anti-fibroticos.
MY185971A (en) Pyranodipyridine compound
EA201390374A1 (ru) Гетероциклические соединения для лечения или профилактики расстройств, вызываемых ослабленной нейротрансмиссией серотонина, норэпинефрина или допамина
AR096160A1 (es) Inhibidores de nicotamida fosforibosiltransferasa, composiciones, productos y usos de los mismos